biotech company – Talk Bio

RyCarma Therapeutics Unveils New Leadership and Company Name, Expands Focus on Heart Failure Treatment

5 months ago talkbio0Tagged ARMGO, biotech company, Cardiovascular Diseases, Changing, Heart failure, Leadership, Pharma, Rycals, RyCarma, skeletal muscle diseases

RyCarma Therapeutics, ARMGO Pharma, ryanodine receptor, Rycals, heart failure, cardiovascular diseases, skeletal muscle diseases, biotech company, new leadership, company name change.

Exsilio Emerges from Stealth with $82 Million to Revolutionize Gene Therapy

12 months ago talkbio0Tagged Approach (spatial), biotech company, Exsilio, gene therapy, Genetic Medicine, Lipids, nanoparticle delivery, New, RNA, Messenger

Exsilio Therapeutics, Gene Therapy, Novel Approach, mRNA, Lipid Nanoparticle Delivery, Biotech Company, Genetic Medicine

Skye Bioscience Abandons Eye Disease Pipeline, Shifts Focus to Obesity Treatment After Phase 2a Trial Failure

12 months ago talkbio0Tagged Bioscience, biotech company, Obesity, Prices, Skye, Trial Phase 2A

Skye Bioscience, eye disease, Phase 2a trial, obesity treatment, stock price, biotech company